Steven Hodak, MD Joins NYULMC Division of Endocrinology, Diabetes, and Metabolism

Takes on roles as divisional Associate Director for Clinical Affairs, Director of the new Center for Diabetes and Endocrinology and Director of Glycemic Control at Tisch Hospital


The following is the April 9, 2014 message to the Department of Medicine staff from from Chair of the Department of Medicine, Steven Abramson, MD, and Director of the Division of Endocrinology, Diabetes, and Metabolism, Ann Danoff, MD:

Dear Colleagues,

We are pleased to announce that Steven Hodak, MD, has been recruited to NYU Langone Medical Center as Associate Director for Clinical Affairs of the Division of Endocrinology, Diabetes and Metabolism. Dr. Hodak will also become the Director of our new Center for Diabetes and Endocrinology and Director of Glycemic Control at Tisch Hospital.

In these important institutional positions, Dr. Hodak will work closely with department and hospital leadership. In addition, he will collaborate with and build upon the legacy of care in thyroid disease established and led by Manfred Blum, MD, director of the Thyroid Unit and Nuclear Endocrinology Division.

Dr. Hodak earned his medical degree from Georgetown University School of Medicine in 1999, where he remained for both his house-staff and fellowship training. In 2005, Dr. Hodak joined the faculty of the University of Pittsburgh (UPMC), where he became director of University of Pittsburgh’s Center for Diabetes and Endocrinology. Shortly thereafter, he also assumed the role of co-director of the University of Pittsburgh Multidisciplinary Thyroid Center. The UPMC Center for Diabetes and Endocrinology is one of the largest clinical endocrinology programs in the United States, with over 25,000 clinical visits annually. The Multidisciplinary Thyroid Center gives patients access to same-day streamlined care from specialists in endocrinology, surgery, radiology, and pathology who provide a broad range of services, including minimally invasive fine-needle aspiration, diagnostic imaging, real-time cytology diagnosis, and surgical consultation, all under one roof in a single visit. Dr. Hodak also led the UPMC Clinical Directors' Council that brings together clinical leadership from across the Department of Medicine to discuss and develop ideas and care delivery models that lead to improved operational efficiencies.

Dr. Hodak’s clinical research activities are centered on the development of molecular diagnostics as applied to evaluation of thyroid nodules. As a member of the Pittsburg thyroid group, Dr. Hodak developed expertise in fine-needle aspiration for biopsies and is part of a collaborative that developed molecular genetic testing that has improved diagnostic yield in fine-needle aspiration biopsy specimens, allowed better risk stratification of thyroid cancer patients, and enhanced current treatment and surveillance protocols. These tools can provide information that will make it possible for physicians to analyze samples obtained from fine-needle thyroid aspiration to better quantify the risks and benefits of surgical intervention of thyroid nodules. Such molecular diagnostics will spare many patients from unnecessary thyroid surgery, and minimize the associated human and economic costs. Dr. Hodak has co-authored more than 25 peer-reviewed articles in this area over the past five years, often serving as the lead clinical researcher who frames important research questions, identifies patients, performs needle biopsies, and develops patient databases and tissue biorepositories required for successful translational research.

Through this work, Dr. Hodak has become nationally recognized in the field, serving on professional committees and speaking widely. He has been thyroid section chair for the Endocrine Society's Clinical Endocrinology Update Steering Committee and he has served the American Thyroid Association on the Clinical Affairs Committee and the Media Affairs Committee.

As a renowned leader in the field, Dr. Hodak will play a significant role in enhancing the clinical and academic mission of the Division of Endocrinology, Diabetes and Metabolism here at NYULMC. Please join us in welcoming Dr. Hodak to New York and NYU Langone Medical Center.

Sincerely yours,

Steven B. Abramson, MD
Frederick H. King Professor and Chair
Department of Medicine

Ann Danoff, MD
Director, Division of Endocrinology, Diabetes and Metabolism